An experimental gene therapy dramatically improved the ability of a young boy with Duchenne muscular dystrophy to rise from the ground or climb stairs, repeating and improving on results seen in three previous patients who received the treatment, which is being developed by Sarepta Therapeutics of Cambridge, Mass.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,